Recorded Webinars

DATE

BY DATE

2023

March

Nothing Works Without the Engine Running: Update on ADVANCED Heart Failure Management
Thursday, 9 March, 2023


This webinar will discuss a variety of topics in the management of an advanced heart failure patient. The use of contemporary therapies such as ARNI, SGLTI, novel anticoagulants, amiodarone, ablation, and inotropes in a heart transplant or LVAD candidate, and the potential implications on transplantation and durable LVAD outcomes. Attendees will gain practical insights from expert speakers on the use of these HF therapies in patients awaiting heart transplantation or durable LVAD therapy.
 

 

January

Escalating and De-Escalating Temporary Mechanical Circulatory Support: Pragmatic Approaches to the Patient in Cardiogenic Shock

Tuesday, 10 January, 2023

When confronted with a patient who presents in cardiogenic shock, as care providers we are faced with persistent high mortality that has not changed appreciably in the last few decades despite the use of temporary mechanical circulatory support (tMCS). During this webinar, speakers will discuss the pragmatic considerations in the escalation and de-escalation of tMCS in patients with cardiogenic shock. Additionally, speakers will propose standardized approaches to the use of tMCS. Lastly, the role of tMCS in LV recovery will be discussed.
 

 
2022

December

Donor Lung Management From the ICU Onwards

Wednesday, 14 December, 2022

Organ preservation starts in the donor ICU and the donor organ journey can significantly impact recipient outcomes. Intensive care clinicians commit to providing the highest number of donor organs in the best possible condition through the optimization of donor physiology.

The webinar will discuss strategies for donor organ optimization prior to organ retrieval and consider the role for centralized donor management. Regulatory, legal, and ethical barriers to deceased organ donor intervention will also be explored.
 

 

May

Xenotransplantation–Crossing the Final Frontier?

Wednesday, 25 May, 2022

The recently performed heart transplantation using a genetically modified pig heart into an adult recipient has catapulted the discussion around xenotransplantation back on the center stage. After decades of research and grown understanding and ability to overcome interspecies differences in animal models, have we now reached the point to justify xenotransplantation into humans?

The session will provide insight into the challenges encountered, the genetic manipulations undertaken to overcome these, surgical concerns and solutions, insight into the clinical course of human xenotransplantation in present and past and discussion around ethical and infectious concerns.
 

 

February

The Ongoing Challenges of CTEPH

Wednesday, 23 February, 2022

The last decade has witnessed a global expansion in the diagnosis and management of patients with chronic thromboembolic disease. This has been fueled by a number of new treatment modalities which have shown considerable promise, particularly in inoperable CTEPH patients. This webinar, presented by leading experts in the field, will address some of the most frequently asked questions by clinicians providing care to this unique patient group.
 
 
 
2021

November

Heart Failure and Guideline-Directed Medical Therapy in LVAD Patients

Wednesday, 17 November, 2021

Management of heart failure does not cease after durable MCS implantation and long-term untreated heart failure and persistent congestion can impact MCS morbidity and mortality. During this webinar, speakers will discuss the evaluation of hemodynamics and biomarkers in this patient population and how to optimize pump parameters to mitigate symptoms and optimize the patient-pump interaction. Additionally, speakers will discuss recent additions to the guideline directed medical therapy armamentarium for heart failure and how data from the heart failure literature can be extrapolated to durable MCS patients. Lastly, recovery, both full and partial will be discussed, and how this further impacts the patient-pump interaction.
 

 

New Insight into the Framing of Antibody-Mediated Rejection in Lung Transplantation

Wednesday, 17 November, 2021

This webinar will provide an update on antibody-mediated rejection (AMR) following lung transplantation, an important cause of graft dysfunction and loss. At this stage, it is critical that lung transplant clinicians, pathologists and immunologists have a strong understanding of the criteria for the timely diagnosis and assessment of AMR and of the approaches to use for the optimal management of such a condition. Following discussion of the index case, brief overviews will be provided by international experts who will present the latest developments in this field, with particular focus on new AMR statement that is soon-to-come.
 

 

October


  

Developing an Award-Winning Research Project: ISHLT2021 Scientific Abstract Award Winners (HEART, MCS, PVD)

Wednesday, 27 October, 2021

This webinar will highlight six Scientific Abstract Award winners from research topics in heart failure and transplantation, mechanical circulatory support, and pulmonary vascular disease. Brief presentations by each presenting author will be followed by an interactive Q&A discussion focusing on the research process and how to develop a great presentation once an abstract has been accepted. The session is geared toward novice researchers and those interested in improving their chances of having their abstract considered for a scientific abstract award.
 

 

Developing an Award-Winning Research Project: ISHLT2021 Scientific Abstract Award Winners (LUNG)

Wednesday, 27 October, 2021

This webinar will highlight six Scientific Abstract Award winners from research topics in lung failure and transplantation. Brief presentations by each presenting author will be followed by an interactive Q&A discussion focusing on the research process and how to develop a great presentation once an abstract has been accepted. The session is geared toward novice researchers and those interested in improving their chances of having their abstract considered for a scientific abstract award.
 
 

September

Under Pressure: PH Management in End Stage Cardiopulmonary Diseases

Wednesday, 29 September, 2021

This webinar will focus on the management of advanced pulmonary hypertension in patients who are candidates for transplantation. How to safely bring these high risk patients at bay is a daily challenge for multidisciplinary teams. Leading experts in the field will share their thoughts and participate in a lively discussion with the ISHLT community.
 

 

Chagas Disease in Heart Transplantation

Wednesday, 29 September, 2021

Six to seven million people in the world live with Chagas disease, a subset of whom will develop Chagas heart disease potentially requiring heart transplantation. In this webinar we will discuss the etiology, pathology, and management of Chagas heart disease, both pre- and post-heart transplantation.
 

 

August

Around the World of Cardiogenic Shock: Interdisciplinary Research and Education

Wednesday, 25 August, 2021

This webinar will highlight global perspectives from active working groups in cardiogenic shock with focused projections on the contributions (registry, consortiums, etc.) of each group/country through the ISHLT interdisciplinary framework.
 

 

July

VAD Implantation: Standard vs Alternative Approaches

Wednesday, 28 July, 2021

Durable mechanical circulatory support improves outcome and quality of life of patients with advanced heart failure. The surgical implantation approach may positively impact the outcome. The optimal surgical approach (median sternotomy vs less invasive approach) remains controversial. This webinar provides in-depth knowledge of the possible advantages of each approach.
 

 

Interactive Live Case Discussion: ECMO Bridge to Lung Transplant: A Bridge Too Far?

Wednesday, 28 July, 2021

This interactive webinar will discuss some of the key issues associated with the “urgent referral for consideration of lung transplant in the patient with pulmonary hypertension who, not known to the transplant program, has crashed onto ECMO”. Following discussion of the index case, brief overviews will be provided by international experts on topics related to compromised assessment pathways, medical therapy of end-stage pulmonary hypertension, ECLS options and post-transplant care in the intensive care unit.

This webinar will cover some challenging situations illustrating the importance of invasive hemodynamic assessment in advances cardiac and respiratory conditions.
 

 

June

Deep Dive into Oral Presentations from ISHLT2021

         
   
   

Wednesday, 16 June, 2021

This webinar features four oral presentations based on top-scoring abstracts, covering a multidisciplinary range of topics spanning all four core therapies featured at the 2021 ISHLT Annual Meeting & Scientific Sessions. The 2021 and 2020 Scientific Program Chairs will conduct in-depth interviews with each presenter, and the program will conclude with a message from the 2022 Scientific Program Chair.
 
 

May

Interactive Live Case Discussion: Failing Fontan and Transplantation

Wednesday, 26 May, 2021

This interactive webinar will provide some of the key problems associated with failing Fontan adult and pediatric patients both before and after transplantation with international experts. Along discussion of an exemplary case, brief overviews will be provided on the current knowledge on protein losing enteropathy, elevated pulmonary vascular pressures, ventricular assist device options and liver assessment and consideration of combined heart liver transplantation followed by open discussion of each point and panel discussion of any other arising questions towards the end of the session.
 
 

All Mod Cons: RHC Pearls and Gems in Pulmonary Hypertension

Wednesday, 26 May, 2021

Right heart catheterization is the gold standard for the assessment of pulmonary hypertension. It is critical at different steps in the differential diagnosis and the distinction between post and pre capillary PH. It also provides insights on outcome and is an important guide for treatment decisions in pulmonary vascular diseases (PAH and CTEPH) and in advanced heart failure (MCS and HTX). Although widely used in clinical practice, RHC requires specific knowledge both in data collection and interpretation of results.

This webinar will cover some challenging situations illustrating the importance of invasive hemodynamic assessment in advances cardiac and respiratory conditions.
 
 

March

The Ongoing COVID-19 Pandemic: Rising to the Challenge

Wednesday, 24 March, 2021

This webinar will provide an update on the ongoing COVID-19 pandemic by focusing on both ends of spectrum from infection prevention to management of severe disease. Speakers will summarize relevant clinical trial data from COVID-19 vaccination trials and what it means for our patients; and also discuss basic pathophysiology of COVID-19 related acute respiratory distress syndrome and new insights in management via extra corporeal membrane oxygenation (ECMO).
 
 

January

Deep Dive on Hot Topics at JHLT

Wednesday, 27 January, 2021

Join the new Editorial Team at the Journal of Heart and Lung Transplantation as they discuss three recent JHLT publications spanning experimental research in lung transplantation, pediatric transplantation, and adult heart transplantation.
 
 
 
2020

December

Anticoagulation and Bleeding Complications in MCS Patients

Wednesday, 16 December, 2020

Developed from ISHLT2020 SESSION 29 (ORAL)
 
 

Building on a Solid Foundation: Guidelines and Unique Challenges in CF Lung Transplant

Wednesday, 16 December, 2020

Developed from ISHLT2020 SUNRISE 04

The focus of this session is to provide an in-depth assessment of CF specific considerations in lung transplant. Recently published referral guidelines will be reviewed with a focus on issues such as adherence and psychosocial factors. Identification of at-risk patients and strategies to enhance waitlist survival will be undertaken. CF specific pre transplant issues and how they influence candidacy will be reviewed including liver disease, non adherence, vascular anatomy and other GIT manifestations.
 
 

November

Update on COVID-19 and Challenges in Cardiothoracic Transplantation

Wednesday, 18 November, 2020

The ongoing COVID-19 pandemic has had significant global impact on cardiothoracic transplantation. The ISHLT COVID-19 webinar will discuss various aspects of the pandemic on heart and lung transplantation using a case-based approach. Topics include infectivity of SAR-CoV-2, management of wait listed patients infected with or exposed to SARS-CoV-2, summary of recent COVID-19 therapeutic trials and implications for transplant recipients, and lung transplant evaluation and listing criteria for COVID-19 related respiratory failure.
 
 

October

Segmental and Subsegmental Disease in CTEPH: Misconception and Missed Opportunities

Wednesday, 28 October, 2020

Developed from ISHLT2020 SESSION 34 (SYMPOSIUM)

This symposium will specifically focus on segmental and subsegmental disease in CTEPH. The management of segmental and subsegmental disease has evolved over the past decade. Pulmonary endarterectomy and balloon pulmonary angioplasty have been shown to be excellent therapeutic options for these patients. However, both options have not yet been widely adopted due to technical challenges.
 
 

Hepatitis C+ Donors for Heart Transplantation: Redefining High Risk

Wednesday, 28 October, 2020

Developed from ISHLT2020 SESSION 72 (ORAL)
 
 

September

When a Single Ventricle Support is Not Enough

Wednesday, 30 September, 2020

Developed from ISHLT2020 SESSION 64 (SYMPOSIUM)

Biventricular failure is associated with high in-hospital mortality. The aim of this session is to explore the clinical utility of extra- and intracorporeal as well as percutaneous MCS for patients persisting biventricular failure. In this session the currently available devices for treating shock and heart failure and a look ahead within this developing field, including new devices and novel indications for established technology should be presented.
 
 

Molecular Mechanisms of Allograft Injury and CLAD

Wednesday, 30 September, 2020

Developed from ISHLT2020 SESSION 69 (ORAL)
 
 

July

Pulmonary Hypertension: Where We're Going We Don't Need Roads

Wednesday, 22 July, 2020

Developed from: ISHLT2020 SESSION 05 (ORAL)
 
 

The Evolving Science of Shock Recognition and Management

Wednesday, 22 July, 2020

Developed from: ISHLT2020 SESSION 02 (SYMPOSIUM)

This session aims to review the evolving understanding of cardiogenic shock, including its varied presentations and trajectories, the importance of hemodynamic data in management, determination of treatment options, and the rapidly growing concept of multidisciplinary shock teams to deliver expedited and patient-centered care.
 
 

June

New Frontiers in Heart and Lung Transplantation: ISHLT2020 Plenary Session Selections II

Wednesday, 24 June, 2020

Features selected content from Plenary Sessions scheduled for presentation at the 2020 Anniversary Meeting and Scientific Sessions, including MAID - Medical Assistance in Dying: Implications for Transplantation by James Downar, MDCM, MHSc and three Featured Abstract Presentations
 
 

May

New Frontiers in Heart and Lung Transplantation: ISHLT2020 Plenary Session Selections I

Wednesday, 27 May, 2020

Features select presentations developed for presentation in Plenary Sessions at the 2020 Anniversary Meeting and Scientific Sessions, including Translating Tissue Engineered Heart Repair by Wolfram Zimmermann, MD, Management of Lung Failure in 2040: Artificial Lung or Regeneration? by Shaf Keshavjee, MD, MSc, FRCSC, FACS, and two Featured Abstract Presentations
 
 

April

COVID-19 and Challenges in Advanced Heart and Lung Disease and Cardiothoracic Transplantation

Wednesday, 29 April, 2020

The rapid spread of COVID-19, caused by the SARS-CoV-2 coronavirus, has affected all aspects of medical care, including advanced heart and lung disease and cardiothoracic transplantation. Clinical presentation, current epidemiology, therapeutic options, critical care, support devices and donor management will be included among the aspects of patient care explored in this session. Additionally, first-hand experiences from the frontlines of the pandemic will be presented.
 
 
 
ALL

ALL

Around the World of Cardiogenic Shock: Interdisciplinary Research and Education

Wednesday, 25 August, 2021

This webinar will highlight global perspectives from active working groups in cardiogenic shock with focused projections on the contributions (registry, consortiums, etc.) of each group/country through the ISHLT interdisciplinary framework.
 

 

Deep Dive into Oral Presentations from ISHLT2021

Wednesday, 16 June, 2021

This webinar features four oral presentations based on top-scoring abstracts, covering a multidisciplinary range of topics spanning all four core therapies featured at the 2021 ISHLT Annual Meeting & Scientific Sessions. The 2021 and 2020 Scientific Program Chairs will conduct in-depth interviews with each presenter, and the program will conclude with a message from the 2022 Scientific Program Chair.
 
 

The Ongoing COVID-19 Pandemic: Rising to the Challenge

Wednesday, 24 March, 2021

This webinar will provide an update on the ongoing COVID-19 pandemic by focusing on both ends of spectrum from infection prevention to management of severe disease. Speakers will summarize relevant clinical trial data from COVID-19 vaccination trials and what it means for our patients; and also discuss basic pathophysiology of COVID-19 related acute respiratory distress syndrome and new insights in management via extra corporeal membrane oxygenation (ECMO).
 
 

Deep Dive on Hot Topics at JHLT

Wednesday, 27 January, 2021

Join the new Editorial Team at the Journal of Heart and Lung Transplantation as they discuss three recent JHLT publications spanning experimental research in lung transplantation, pediatric transplantation, and adult heart transplantation.
 
 

Update on COVID-19 and Challenges in Cardiothoracic Transplantation

Wednesday, 18 November, 2020

The ongoing COVID-19 pandemic has had significant global impact on cardiothoracic transplantation. The ISHLT COVID-19 webinar will discuss various aspects of the pandemic on heart and lung transplantation using a case-based approach. Topics include infectivity of SAR-CoV-2, management of wait listed patients infected with or exposed to SARS-CoV-2, summary of recent COVID-19 therapeutic trials and implications for transplant recipients, and lung transplant evaluation and listing criteria for COVID-19 related respiratory failure.
 
 

New Frontiers in Heart and Lung Transplantation: ISHLT2020 Plenary Session Selections II

Wednesday, 24 June, 2020

Features selected content from Plenary Sessions scheduled for presentation at the 2020 Anniversary Meeting and Scientific Sessions, including MAID - Medical Assistance in Dying: Implications for Transplantation by James Downar, MDCM, MHSc and three Featured Abstract Presentations
 
 

New Frontiers in Heart and Lung Transplantation: ISHLT2020 Plenary Session Selections I

Wednesday, 27 May, 2020

Features select presentations developed for presentation in Plenary Sessions at the 2020 Anniversary Meeting and Scientific Sessions, including Translating Tissue Engineered Heart Repair by Wolfram Zimmermann, MD, Management of Lung Failure in 2040: Artificial Lung or Regeneration? by Shaf Keshavjee, MD, MSc, FRCSC, FACS, and two Featured Abstract Presentations
 
 

COVID-19 and Challenges in Advanced Heart and Lung Disease and Cardiothoracic Transplantation

Wednesday, 29 April, 2020

The rapid spread of COVID-19, caused by the SARS-CoV-2 coronavirus, has affected all aspects of medical care, including advanced heart and lung disease and cardiothoracic transplantation. Clinical presentation, current epidemiology, therapeutic options, critical care, support devices and donor management will be included among the aspects of patient care explored in this session. Additionally, first-hand experiences from the frontlines of the pandemic will be presented.
 
 
HEART

HEART

Nothing Works Without the Engine Running: Update on ADVANCED Heart Failure Management

Thursday, 9 March, 2023

This webinar will discuss a variety of topics in the management of an advanced heart failure patient. The use of contemporary therapies such as ARNI, SGLTI, novel anticoagulants, amiodarone, ablation, and inotropes in a heart transplant or LVAD candidate, and the potential implications on transplantation and durable LVAD outcomes. Attendees will gain practical insights from expert speakers on the use of these HF therapies in patients awaiting heart transplantation or durable LVAD therapy.
 

 

Xenotransplantation–Crossing the Final Frontier?

Wednesday, 25 May, 2022

The recently performed heart transplantation using a genetically modified pig heart into an adult recipient has catapulted the discussion around xenotransplantation back on the center stage. After decades of research and grown understanding and ability to overcome interspecies differences in animal models, have we now reached the point to justify xenotransplantation into humans?

The session will provide insight into the challenges encountered, the genetic manipulations undertaken to overcome these, surgical concerns and solutions, insight into the clinical course of human xenotransplantation in present and past and discussion around ethical and infectious concerns.
 

 

Developing an Award-Winning Research Project: ISHLT2021 Scientific Abstract Award Winners (HEART, MCS, PVD)

Wednesday, 27 October, 2021

This webinar will highlight six Scientific Abstract Award winners from research topics in heart failure and transplantation, mechanical circulatory support, and pulmonary vascular disease. Brief presentations by each presenting author will be followed by an interactive Q&A discussion focusing on the research process and how to develop a great presentation once an abstract has been accepted. The session is geared toward novice researchers and those interested in improving their chances of having their abstract considered for a scientific abstract award.
 

 

Chagas Disease in Heart Transplantation

Wednesday, 29 September, 2021

Six to seven million people in the world live with Chagas disease, a subset of whom will develop Chagas heart disease potentially requiring heart transplantation. In this webinar we will discuss the etiology, pathology, and management of Chagas heart disease, both pre- and post-heart transplantation.
 

 

Interactive Live Case Discussion: Failing Fontan and Transplantation

Wednesday, 26 May, 2021

This interactive webinar will provide some of the key problems associated with failing Fontan adult and pediatric patients both before and after transplantation with international experts. Along discussion of an exemplary case, brief overviews will be provided on the current knowledge on protein losing enteropathy, elevated pulmonary vascular pressures, ventricular assist device options and liver assessment and consideration of combined heart liver transplantation followed by open discussion of each point and panel discussion of any other arising questions towards the end of the session.
 
 

Hepatitis C+ Donors for Heart Transplantation: Redefining High Risk

Wednesday, 28 October, 2020

Developed from ISHLT2020 SESSION 72 (ORAL)
 
 

The Evolving Science of Shock Recognition and Management

Wednesday, 22 July, 2020

Developed from: ISHLT2020 SESSION 02 (SYMPOSIUM)

This session aims to review the evolving understanding of cardiogenic shock, including its varied presentations and trajectories, the importance of hemodynamic data in management, determination of treatment options, and the rapidly growing concept of multidisciplinary shock teams to deliver expedited and patient-centered care.
 
 
LUNG

LUNG

Donor Lung Management From the ICU Onwards

Wednesday, 14 December, 2022

Organ preservation starts in the donor ICU and the donor organ journey can significantly impact recipient outcomes. Intensive care clinicians commit to providing the highest number of donor organs in the best possible condition through the optimization of donor physiology.

The webinar will discuss strategies for donor organ optimization prior to organ retrieval and consider the role for centralized donor management. Regulatory, legal, and ethical barriers to deceased organ donor intervention will also be explored.
 

 

New Insight into the Framing of Antibody-Mediated Rejection in Lung Transplantation

Wednesday, 17 November, 2021

This webinar will provide an update on antibody-mediated rejection (AMR) following lung transplantation, an important cause of graft dysfunction and loss. At this stage, it is critical that lung transplant clinicians, pathologists and immunologists have a strong understanding of the criteria for the timely diagnosis and assessment of AMR and of the approaches to use for the optimal management of such a condition. Following discussion of the index case, brief overviews will be provided by international experts who will present the latest developments in this field, with particular focus on new AMR statement that is soon-to-come.
 

 

Developing an Award-Winning Research Project: ISHLT2021 Scientific Abstract Award Winners (LUNG)

Wednesday, 27 October, 2021

This webinar will highlight six Scientific Abstract Award winners from research topics in lung failure and transplantation. Brief presentations by each presenting author will be followed by an interactive Q&A discussion focusing on the research process and how to develop a great presentation once an abstract has been accepted. The session is geared toward novice researchers and those interested in improving their chances of having their abstract considered for a scientific abstract award.
 
 

Interactive Live Case Discussion: ECMO Bridge to Lung Transplant: A Bridge Too Far?

Wednesday, 28 July, 2021

This interactive webinar will discuss some of the key issues associated with the “urgent referral for consideration of lung transplant in the patient with pulmonary hypertension who, not known to the transplant program, has crashed onto ECMO”. Following discussion of the index case, brief overviews will be provided by international experts on topics related to compromised assessment pathways, medical therapy of end-stage pulmonary hypertension, ECLS options and post-transplant care in the intensive care unit.

This webinar will cover some challenging situations illustrating the importance of invasive hemodynamic assessment in advances cardiac and respiratory conditions.
 

 

Building on a Solid Foundation: Guidelines and Unique Challenges in CF Lung Transplant

Wednesday, 16 December, 2020

Developed from ISHLT2020 SUNRISE 04

The focus of this session is to provide an in-depth assessment of CF specific considerations in lung transplant. Recently published referral guidelines will be reviewed with a focus on issues such as adherence and psychosocial factors. Identification of at-risk patients and strategies to enhance waitlist survival will be undertaken. CF specific pre transplant issues and how they influence candidacy will be reviewed including liver disease, non adherence, vascular anatomy and other GIT manifestations.
 
 

Molecular Mechanisms of Allograft Injury and CLAD

Wednesday, 30 September, 2020

Developed from ISHLT2020 SESSION 69 (ORAL)
 
 
MCS

MCS

 

Escalating and De-Escalating Temporary Mechanical Circulatory Support: Pragmatic Approaches to the Patient in Cardiogenic Shock

Tuesday, 10 January, 2023

When confronted with a patient who presents in cardiogenic shock, as care providers we are faced with persistent high mortality that has not changed appreciably in the last few decades despite the use of temporary mechanical circulatory support (tMCS). During this webinar, speakers will discuss the pragmatic considerations in the escalation and de-escalation of tMCS in patients with cardiogenic shock. Additionally, speakers will propose standardized approaches to the use of tMCS. Lastly, the role of tMCS in LV recovery will be discussed.
 

 

Heart Failure and Guideline-Directed Medical Therapy in LVAD Patients

Wednesday, 17 November, 2021

Management of heart failure does not cease after durable MCS implantation and long-term untreated heart failure and persistent congestion can impact MCS morbidity and mortality. During this webinar, speakers will discuss the evaluation of hemodynamics and biomarkers in this patient population and how to optimize pump parameters to mitigate symptoms and optimize the patient-pump interaction. Additionally, speakers will discuss recent additions to the guideline directed medical therapy armamentarium for heart failure and how data from the heart failure literature can be extrapolated to durable MCS patients. Lastly, recovery, both full and partial will be discussed, and how this further impacts the patient-pump interaction.
 

 

Developing an Award-Winning Research Project: ISHLT2021 Scientific Abstract Award Winners (HEART, MCS, PVD)

Wednesday, 27 October, 2021

This webinar will highlight six Scientific Abstract Award winners from research topics in heart failure and transplantation, mechanical circulatory support, and pulmonary vascular disease. Brief presentations by each presenting author will be followed by an interactive Q&A discussion focusing on the research process and how to develop a great presentation once an abstract has been accepted. The session is geared toward novice researchers and those interested in improving their chances of having their abstract considered for a scientific abstract award.
 

 

VAD Implantation: Standard vs Alternative Approaches

Wednesday, 28 July, 2021

Durable mechanical circulatory support improves outcome and quality of life of patients with advanced heart failure. The surgical implantation approach may positively impact the outcome. The optimal surgical approach (median sternotomy vs less invasive approach) remains controversial. This webinar provides in-depth knowledge of the possible advantages of each approach.
 

 

Anticoagulation and Bleeding Complications in MCS Patients

Wednesday, 16 December, 2020

Developed from ISHLT2020 SESSION 29 (ORAL)
 
 

When a Single Ventricle Support is Not Enough

Wednesday, 30 September, 2020

Developed from ISHLT2020 SESSION 64 (SYMPOSIUM)

Biventricular failure is associated with high in-hospital mortality. The aim of this session is to explore the clinical utility of extra- and intracorporeal as well as percutaneous MCS for patients persisting biventricular failure. In this session the currently available devices for treating shock and heart failure and a look ahead within this developing field, including new devices and novel indications for established technology should be presented.
 
 
PVD

PVD

The Ongoing Challenges of CTEPH

Wednesday, 23 February, 2022

The last decade has witnessed a global expansion in the diagnosis and management of patients with chronic thromboembolic disease. This has been fueled by a number of new treatment modalities which have shown considerable promise, particularly in inoperable CTEPH patients. This webinar, presented by leading experts in the field, will address some of the most frequently asked questions by clinicians providing care to this unique patient group.
 

 

Developing an Award-Winning Research Project: ISHLT2021 Scientific Abstract Award Winners (HEART, MCS, PVD)

Wednesday, 27 October, 2021

This webinar will highlight six Scientific Abstract Award winners from research topics in heart failure and transplantation, mechanical circulatory support, and pulmonary vascular disease. Brief presentations by each presenting author will be followed by an interactive Q&A discussion focusing on the research process and how to develop a great presentation once an abstract has been accepted. The session is geared toward novice researchers and those interested in improving their chances of having their abstract considered for a scientific abstract award.
 

 

Under Pressure: PH Management in End Stage Cardiopulmonary Diseases

Wednesday, 29 September, 2021

This webinar will focus on the management of advanced pulmonary hypertension in patients who are candidates for transplantation. How to safely bring these high risk patients at bay is a daily challenge for multidisciplinary teams. Leading experts in the field will share their thoughts and participate in a lively discussion with the ISHLT community.
 

 

All Mod Cons: RHC Pearls and Gems in Pulmonary Hypertension

Wednesday, 26 May, 2021

Right heart catheterization is the gold standard for the assessment of pulmonary hypertension. It is critical at different steps in the differential diagnosis and the distinction between post and pre capillary PH. It also provides insights on outcome and is an important guide for treatment decisions in pulmonary vascular diseases (PAH and CTEPH) and in advanced heart failure (MCS and HTX). Although widely used in clinical practice, RHC requires specific knowledge both in data collection and interpretation of results.

This webinar will cover some challenging situations illustrating the importance of invasive hemodynamic assessment in advances cardiac and respiratory conditions.
 
 

Segmental and Subsegmental Disease in CTEPH: Misconception and Missed Opportunities

Wednesday, 28 October, 2020

Developed from ISHLT2020 SESSION 34 (SYMPOSIUM)

This symposium will specifically focus on segmental and subsegmental disease in CTEPH. The management of segmental and subsegmental disease has evolved over the past decade. Pulmonary endarterectomy and balloon pulmonary angioplasty have been shown to be excellent therapeutic options for these patients. However, both options have not yet been widely adopted due to technical challenges.
 
 

Pulmonary Hypertension: Where We're Going We Don't Need Roads

Wednesday, 22 July, 2020

Developed from: ISHLT2020 SESSION 05 (ORAL)